This webinar highlights findings from a large-scale retrospective study at Baylor St. Luke's Medical Center, evaluating the clinical impact of microbial cell-free DNA (mcfDNA) sequencing in solid organ transplant (SOT) recipients. This webinar provides insight into the evolving landscape of infection risks in SOT patients, and how mcfDNA testing can address diagnostic challenges in cases like fever of unknown origin, complicated pneumonia, and invasive fungal infections. The session also demonstrates how the test’s rapid turnaround and comprehensive pathogen detection may contribute to better clinical outcomes.